tiprankstipranks
Biotricity Inc (BTCY)
OTHER OTC:BTCY
US Market
Holding BTCY?
Track your performance easily

Biotricity (BTCY) Stock Price & Analysis

116 Followers

BTCY Stock Chart & Stats


Financials

Annual

Ownership Overview

0.20%99.80%
Insiders
Mutual Funds
0.20% Other Institutional Investors
99.80% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

BTCY FAQ

What was Biotricity Inc’s price range in the past 12 months?
Biotricity Inc lowest stock price was $0.19 and its highest was $1.67 in the past 12 months.
    What is Biotricity Inc’s market cap?
    Biotricity Inc’s market cap is $8.84M.
      When is Biotricity Inc’s upcoming earnings report date?
      Biotricity Inc’s upcoming earnings report date is Feb 18, 2025 which is in 30 days.
        How were Biotricity Inc’s earnings last quarter?
        Biotricity Inc released its earnings results on Nov 15, 2024. The company reported -$0.073 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.073.
          Is Biotricity Inc overvalued?
          According to Wall Street analysts Biotricity Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Biotricity Inc pay dividends?
            Biotricity Inc does not currently pay dividends.
            What is Biotricity Inc’s EPS estimate?
            Biotricity Inc’s EPS estimate is -0.11.
              How many shares outstanding does Biotricity Inc have?
              Biotricity Inc has 24,394,442 shares outstanding.
                What happened to Biotricity Inc’s price movement after its last earnings report?
                Biotricity Inc reported an EPS of -$0.073 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 12.5%.
                  Which hedge fund is a major shareholder of Biotricity Inc?
                  Currently, no hedge funds are holding shares in BTCY
                  ---

                  Company Description

                  Biotricity Inc

                  Biotricity, Inc. engages in the provision of biometric data monitoring solutions. The firm offers the Bioflux, a single-unit mobile cardiac telemetry device. It also develops Biolife, which is intended for chronic disease prevention. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on August 29, 2012 and is headquartered in Redwood City, CA.
                  ---

                  BTCY Earnings Call

                  Q2 2024
                  0:00 / 0:00
                  Earnings Call Sentiment|Positive
                  The earnings call presents a predominantly positive outlook with significant achievements in EBITDA, revenue growth, strategic partnerships, and market expansion. Despite the continued net loss, the improvements and strategic advancements position Biotricity well for future profitability.Read More>
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Vericel
                  T2 Biosystems
                  Myomo
                  AxoGen
                  Senseonics Holdings
                  Helius Medical Technologies
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis